Figures
Abstract
Objectives
We aimed to explore the impacts of individual and environmental socioeconomic status (SES) on the outcome of peritoneal dialysis (PD) in regions with significant SES disparity, through a retrospective multicenter cohort in China.
Methods
Overall, 2,171 incident patients from seven PD centers were included. Individual SES was evaluated from yearly household income per person and education level. Environmental SES was represented by regional gross domestic product (GDP) per capita and medical resources. Undeveloped regions were defined as those with regional GDP lower than the median. All-cause and cardiovascular death and initial peritonitis were recorded as outcome events.
Results
Poorer PD patients or those who lived in undeveloped areas were younger and less-educated and bore a heavier burden of medical expenses. They had lower hemoglobin and serum albumin at baseline. Low income independently predicted the highest risks for all-cause or cardiovascular death and initial peritonitis compared with medium and high income. The interaction effect between individual education and regional GDP was determined. In undeveloped regions, patients with an elementary school education or lower were at significantly higher risk for all-cause death but not cardiovascular death or initial peritonitis compared with those who attended high school or had a higher diploma. Regional GDP was not associated with any outcome events.
Conclusion
Low personal income independently influenced all-cause and cardiovascular death, and initial peritonitis in PD patients. Education level predicted all-cause death only for patients in undeveloped regions. For PD patients in these high risk situations, integrated care before dialysis and well-constructed PD training programs might be helpful.
Citation: Xu R, Han Q-F, Zhu T-Y, Ren Y-P, Chen J-H, Zhao H-P, et al. (2012) Impact of Individual and Environmental Socioeconomic Status on Peritoneal Dialysis Outcomes: A Retrospective Multicenter Cohort Study. PLoS ONE 7(11): e50766. https://doi.org/10.1371/journal.pone.0050766
Editor: Matthias Eberl, Cardiff University School of Medicine, United Kingdom
Received: July 30, 2012; Accepted: October 24, 2012; Published: November 30, 2012
Copyright: © 2012 Xu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study is supported by Baxer Clinical Research Award from Baxter Corp, China and ISN Research Award from ISN GO R&P Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have the following interests. This work was supported in part by the Baxer Clinical Research Award of Baxter Corp. There are no patents, products in development or marketed products to declare. This does not alter authors’ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Introduction
Recently, the China National Survey of Chronic Kidney Disease Working Group reported that the prevalence of chronic kidney disease was 10.8%, close to that in Western countries [1]. It is predicted that end stage renal disease (ESRD) will increase rapidly and become highly prevalent [2]. In China, medical insurance will be extended to cover all ESRD patients as proposed in a government working report in 2012 (http://english.gov.cn/official/2012-03/15/content_2092737.htm). Because peritoneal dialysis (PD) is less expensive [3], has a comparable survival rate [4], [5] and can confer a better quality of life than hemodialysis (HD) [6], [7], a series of healthcare policies have been considered to increase the penetration of PD (http://www.moh.gov.cn/publicfiles/business/htmlfiles/chenz/pldjh/201107/52373.htm). At present, the possibility of popularizing PD treatment for ESRD patients urgently needs to be explored.
As a home-care therapy, PD requires patients to self-monitor and self-manage their treatment [8], [9], [10], abilities that are closely associated with socioeconomic status (SES) [11], [12]. SES has been investigated for its association with the outcomes of treatment in the general population and in patients with chronic kidney disease at the individual [13], [14], [15], [16], [17] and environmental [13], [15], [16], [17], [18] level. A few large-scale multi-center cohort studies have also explored this issue in PD patients and shown inconsistencies in the impact of individual [19], [20], [21], [22], [23] and environmental [21], [22], [24], [25], [26], [27] SES on PD outcome. In China, we have experienced great economic development in the last 20 years, with an increase in gross domestic product (GDP) of around 10% per year, but there are imbalances between regions. Individual income and education levels also vary markedly within regions and probably lead to diverse availability of medical facilities and health-care services. Given this situation, a specific model is needed to determine whether variations in individual or environmental SES influence PD outcome. Moreover, the interaction between individual and environmental SES on PD outcome, which has never been studied in a dialysis population, should be explored.
This multicenter large-scale retrospective cohort study will be helpful in providing evidence for clinicians deciding whether PD is suitable for individuals with differing SES, and for health policy-makers exploring potential strategies for establishing PD programs in regions with varying SES in China and other developing countries.
Methods
Center Enrollment
Centers with professional PD doctors and nurses and well-developed databases maintained for least 3 years, recording baseline characteristics and follow-up data for Chinese patient every 1∼3 months, participated in this study voluntarily. Nine centers were qualified, and seven of these, accouting for about 70% of all incident patients attending the nine centers, agreed to participate. The included PD centers were located in five different provinces and four geographical regions (north, northeast, northwest, and east) of China. Data from each center were collected within a strict quality control framework and further inspected and optimized to ensure the integrity and accuracy of the database. All study investigators and staff members completed a training program that taught them the methods and processes of the study. A manual of detailed instructions for data collection was distributed. The ethics committee of Peking University First Hospital approved the study.
Subject Selection
All incident patients receiving chronic PD between the date of intact database creation and August 2011 were enrolled into this study. After starting PD, each patient signed informed consent agreeing to the use of their demographic and laboratory data in future studies. All subjects began the PD program within 1 month after catheter implantation and were given lactate-buffered glucose dialysate with a twin-bag connection system (Baxter Healthcare, Guangzhou, China). Patients who had been on PD for less than 3 months were excluded, as in previous studies [20], [21].
*Adjusted hazard ratio with 95% confidence interval (adjusted for confounders such as age, gender, body mass index, diabetes, cardiovascular disease, hemoglobin, serum albumin, and residual renal function, and stratified by center size) **Undeveloped region: gross domestic product (GDP) per capita <¥95,000 ($15,009); developed region: GDP per capita≥¥95,000 ($15,009).
Data Collection
Demographic and clinical data including age, gender, body mass index (BMI), primary renal disease, history of cardiovascular disease (CVD), and presence of diabetes mellitus (DM) were collected at baseline. CVD was recorded if one of the following conditions was present: angina, class III/IV congestive heart failure (New York Heart Association), transient ischemic attack, history of myocardial infarction or cerebrovascular accident, or peripheral arterial disease [28]. Baseline biochemistry data including hemoglobin and serum albumin were calculated as the mean of measurements made during the first 3 months. Dialysis adequacy and residual renal function (RRF) were measured during the first 6 months. RRF was defined as the mean of residual creatinine clearance and residual urea clearance. Dialysis adequacy was determined from the total Kt/V and total creatinine clearance. Center size was also recorded according to the number of enrolled patients from each center.
SES data were collected for each patient. Individual income level was defined as the yearly household income per person and was divided into low (<¥20,000, <$3160,), medium (¥20,000–40,000, $3160–6320) and high (>¥40,000, >$6320); because most of the subjects were from urban areas, these groups were defined according to the average income for the urban population in 2011, obtained from the Bureau of Statistics (http://www.bjstats.gov.cn/nj/main/2011-tjnj/index.htm). The exchange rate of the US dollar ($) to the Chinese Yuan (¥) was set at 6.3293 on November 1, 2011. Education levels were recorded according to diplomas obtained based on school level, that is, elementary school or lower, middle school, high school, or above high school. Other individual SES data included the proportion of individual income used for medical expenses (the percentage of yearly household income per person spent each year on self-paid medical expenses), occupation, rural or urban residence, living alone or not, travel distance from the PD center, and frequency of visits to the PD center. A frequent visitor was defined as someone who saw a doctor at least once every 3 months. Regional SES included regional GDP per capita and regional medical resources such as number of registered doctors and available hospital beds per inhabitant. Data were obtained from the Bureau of Statistics in each province; Beijing data were downloaded from http://www.bjstats.gov.cn/nj/main/2011-tjnj/index.htm. Regions were divided into undeveloped regions and developed according to the median of regional GDP per capita (¥95000, $15009).
Definition of Outcome Events
The Primary outcome was all-cause death or cardiovascular death. Cardiovascular death was defined as death due to myocardial infarction, congestive heart failure, cerebral bleeding, cerebral infarction, arrhythmia, or peripheral arterial disease, or sudden death. The secondary outcome was initial peritonitis, which was diagnosed according to International Society for Peritoneal Dialysis 2010 guidelines [29]. In all analyses, we censored follow-up at transferring to HD, loss to follow-up, renal transplantation, or the end of the study (November 1, 2011).
Statistical Analysis
Continuous data were presented as means with standard deviation except for distance to PD center, RRF, and total Kt/V, which were presented as the median (interquartile range) because of high skew. Categorical variables were presented as proportions. Relevant characteristics were compared between different individual income groups and between different education groups, respectively. Patient data were compared using the t-test or the analysis of variance F-test for normally distributed continuous variables, the chi-square test for categorical variables, or the Mann–Whitney U test for skewed continuous variables.
To determine predictors of outcome events, univariable Cox regression models were first constructed to explore individually the potential risk factors for all-cause death including demographic and bioclinical data, individual income, education level, and regional GDP per capita. Risk factors identified from univariable Cox regression models were included in multivariable analyses with all-cause death, CVD death and initial peritonitis as events. In multivariable analysis, stratified Cox regression models with center size as the stratified factor were employed to adjust for center effects. The center effect was reflected not only in disparity of center size (ranging from 78 patients to 815 patients), which has been demonstrated to be an independent predictor of PD outcome [30], [31], [32], but also in differences in practice patterns and biochemical assays between centers, which differed from the regional effect. The regional effect was defined by regional GDP per capita and reflected differences in SES between regions. To determine whether individual income or education level interacted with regional GDP per capita, we explored their two-way interaction effects on the likelihood of patient survival and peritonitis-free survival. When an interactive effect was observed, subgroup analysis was performed.
We reported the multivariable adjusted hazard ratios (HRs) with 95% confidence interval (CI). All probabilities were two-tailed, and the level of significance was set at 0.05. Statistical analyses were performed using SPSS for Windows software version 13.0 (SPSS Inc., Chicago, IL).
Results
Baseline Characteristics
Data from 2409 patients were collected. One hundred and forty-five patients were excluded because they began the PD program before the date of intact database creation or more than 1 month after catheter implantation. Another 93 patients who had been receiving PD for less than 3 months were also excluded. The included 2171 patients had a mean age of 58.0±15.5 years and BMI 22.9±3.6 kg/m2; 37.6% were diabetic and CVD was present in 40.9% of the subjects at baseline. Chronic glomerulonephritis (CGN) was the most common cause of ESRD (34.9%), followed by diabetic nephropathy and hypertensive nephropathy. The proportions of patients with low, median and high income were 36.5%, 39.8% and 23.7% respectively; 44.3% had a diploma from high school or above. There was significant regional economic disparity across the whole cohort, with GDP per capita ranging from the 10th percentile at ¥24,768 ($3913) to the 90th percentile at ¥175,495 ($27,722). Undeveloped regions were areas with GDP per capita lower than the median (¥95,000, $15,009) and had fewer registered doctors than developed regions but comparable numbers of available hospital beds per thousand inhabitants (4.5±2.3 vs 6.2±1.7, P<0.001 for doctors; 7.7±5.1 vs 7.8±3.0, P = 0.49 for beds).
Socioeconomic and Clinic Characteristics
Patients with low individual income were less likely to be elderly (33.0%) and have a history of CVD (37.5%). The lowest individual incomes were associated with the lowest education level and highest proportion of individual income used for medical expenses. The poorest patients were also more likely to live in rural areas and undeveloped regions at the greatest distances from hospital. Accordingly, the percentage of frequent visitors was lowest in the low individual income group. At baseline, hemoglobin and serum albumin were lowest in the low individual income group. However, gender, BMI, prevalence of DM and CGN, living alone, RRF, baseline dialysis dose, and total Kt/V did not differ significantly between income groups (Table 1).
Patients who lived in undeveloped regions were significantly younger, poorer, and less educated and lived further from hospital. There were more cases of diabetes and fewer cases of CGN in this group. Hemoglobin and serum albumin were lower, but RRF and dialysis dose were comparable to those in developed regions. Undeveloped regions had fewer registered doctors per thousand inhabitants than developed regions. These data are shown in Table 2.
Follow-up and Outcome
The median follow-up time was 27.7(15.5–45) months. As shown in Table 3, among 553 patients who died, 210 deaths (38%) were due to CVD and 140 (25.3%) to infection; other causes were malignancy, gastrointestinal bleeding, malnutrition, miscellaneous, and undefined. Of the 210 patients who died from CVD, the leading cause was myocardial infarction (46 cases, 21.9%); other causes were congestive heart failure, cerebral bleeding, cerebral infarction, arrhythmia, peripheral arterial disease, sudden death, and undefined. One hundred and sixty-eight patients were transferred to HD, most due to PD-associated infection (77 cases, 45.8%); other reasons were leakage, hernia, catheter disposition, ultrafiltration failure, severe congestive heart failure, inadequacy of dialysis, miscellaneous, and undefined.
The time to first-episode peritonitis was 23.7 (11.9–40.4) months. Four hundred and fifty-five episodes of initial peritonitis occurred during the study period; 160 episodes (35.2%) were due to Gram-positive organisms, 94 (20.7%) to Gram-negative organisms, and six (1.3%) to fungi; 12 (2.6%) were polymicrobial, 130 (28.6%) were culture negative and 53 had no culture result (11.6%).
Association between SES and Outcome
On univariable Cox regression analysis, individual income and education level but not regional GDP per capita were significantly associated with all-cause death. The predicted role of these factors were further explored by multivariable Cox regression analysis. Age, BMI, DM, CVD, hemoglobin, serum albumin, RRF, and center size were also found to be significantly associated with all-cause death on univariable Cox regression analysis. After stratification by center and controlling for all of these confounders and gender, compared with the low income group, the adjusted HRs for all-cause death in the medium and high income group were 0.62 (95%CI 0.48–0.79, P<0.001) and 0.44 (95%CI 0.33–0.61, P<0.001) respectively. Medium income and high income were also associated with significantly lower risks for cardiovascular death, with adjusted HRs of 0.60 (95%CI 0.41–0.90 P = 0.012) and 0.47 (95%CI 0.29–0.76, P = 0.002) respectively. The high income group, but not the medium income group had a significantly lower risk for initial peritonitis, with an adjusted HR of 0.69 (95%CI 0.50–0.94, P = 0.02) compared with the low income group (Table 4).
Compared with patients with an elementary school education or lower, patients with higher education levels did not show a constant trend toward lower risk for all-cause death. Only a diploma above the high school level predicted significantly lower risk for all-cause death, with an adjusted HR of 0.68 (95%CI 0.50–0.93, P = 0.02), and for cardiovascular death, with an adjusted HR of 0.54 (95%CI 0.32–0.91, P = 0.02). Otherwise, education level had no effect on cardiovascular death or initial peritonitis (Table 4).
Compared with patients living in undeveloped regions, patients in developed regions had similar risk of cardiovascular or all-cause death and initial peritonitis, even after controlling for all of above mentioned confounders such as age, proportion of patients with diabetes, serum albumin, and so on (Table 4).
In addition, we explored the interactive effect between individual income, education level and regional GDP per capita. We found that individual education but not income level had a significant interactive effect with regional GDP per capita on all-cause death (adjusted HR 0.79, 95% CI 0.65–0.97, P = 0.024), and this influence was further explored after stratifying the patients according to regional development. In undeveloped regions, an education level of high school or above predicted a significantly lower risk for all-cause death compared with elementary school or lower, with adjusted HRs of 0.56 (95% CI 0.34–0.94, P = 0.03) and 0.36 (95% CI 0.20–0.63, P<0.001), respectively. In developed regions, education level did not predict all-cause death (Fig. 1). No interaction effects were observed between individual income or education and regional GDP in terms of cardiovascular death and initial peritonitis.
Discussion
From this first large-scale multi-center cohort of incident Chinese PD patients, we found that individual rather than regional income independently predicted all-cause death, cardiovascular death, and initial peritonitis. Education level was only significantly associated with all-cause death in undeveloped regions but not in developed regions. An interaction effect of individual education level and environmental SES is reported for the first time.
Consistent with former studies [19], [33], [34], [35], lower individual income emerged as an independently significant risk indicator for death and initial peritonitis. Although poorer patients were younger and had less comorbidity, they bore a heavier burden of medical expenses and had access to fewer medical resources, which strongly supports increasing the personal medical coverage rate for PD patients in China. Of note, poorer patients were prone to be anemic and malnourished at baseline, probably due to inadequate health care and late referral to nephrologists before the development of ESRD. Given that the standard chronic kidney disease program is helpful in retarding progression to ESRD and improving complications such as anemia, malnutrition and bone mineral disease [36], [37], the timing of and strategies used for medical support before dialysis in China need to be urgently investigated. We note that effective medical support aids the establishment of successful PD programs for disadvantaged minorities [38], [39].
By contrast, no impact of regional GDP per capita on PD outcome was observed, the opposite of previous findings showing an independently negative effect of regional SES on outcome in chronic disease [15], [16], [17]. One potential reason for our finding is that, in the undeveloped regions in our study, the patients were younger, there were fewer cases of diabetes, and baseline serum albumin levels were higher than in the developed regions. Given that age, diabetes and serum albumin have been recognized as the strongest predictors by most studies [40], [41], [42], these favorable individual factors in our study possibly offset the disadvantages of regional SES. A similar finding was obtained in a study from the USA [24], in which the risk of technique failure was significantly lower in remote-dwelling patients than in those living closer to the hospital, because the former were younger and had fewer complications from diabetes. However, no association between regional SES and cardiovascular or all-cause death or initial peritonitis was observed, even after adjustment for age, proportion of patients with diabetes, serum albumin, and so on. We hypothesize that unknown confounding factors related to regional SES are also associated with PD outcome. In addition, only baseline characteristics, and not the change trend in clinical variables, were analyzed for the prediction of outcome during follow-up. This choice may have influenced the reliability of our results.
Our analysis indicates that education level had no effect on risk of initial peritonitis. This result is consistent with the analysis of a US regional ESRD registry in which 1595 new PD patients were observed over 2 years [23], but is contrary to recently published data from Brazil and Canada [21], [22]. One possible explanation is that our selected centers had professional PD doctors/nurses and well-constructed training programs. Patients and their home-care helpers were often trained simultaneously, which probably led to stronger family support [43]. Whether better compliance in Asian people [44], [45] plays a role in this phenomemon is unclear. However, lower education level still significantly predicted death in undeveloped regions. The causes for this finding are unknown, but it has been shown that PD networks linking developed and developing units might be a means of improving the quality of therapy [46]. Whether the establishment of a standardized PD program in undeveloped regions will benefit less-educated patients needs to be investigated. More trials are also needed to explore new strategies for improving the efficacy of training for less-educated patients.
Our large-scale multicenter PD cohort gave us a valuable opportunity to explore the association of SES and outcome at both the individual and the environmental level. Our results will be helpful for PD clinicians and health policy-makers in generating appropriate strategies to improve the use of PD in developing countries such as China. Compared with former studies, this study has the advantage of more detailed information on individual SES. The enrollment of representative centers in a rapidly developing country with huge diversity in regional economic development is also a merit. The interactive effect between individual and regional SES has never been investigated in a dialysis population.
This study has some limitations. First, based on estimates of the size of the dialysis population (no registry data available as yet), only about 10% of PD patients in China were enrolled in the study and thus we cannot confirm the generalizability of our results. However, all incident patients were enrolled from ‘core’ PD centers of medical school-affiliated hospitals and came from provinces and counties with varied level of SES and penetration rate of PD therapy. Therefore, it is reasonable to conclude that the range of SES of our study population reflects the overall situation to a certain degree. A national dialysis registry has been initiated recently, so more representative data will be obtained in future years. We Hope our study will provide useful cues for the analysis of national data in the future. Second, individual SES is a general index and many SES-related physiological and non-physiological factors were not measured. We cannot verify whether worse nutritional status, deficient pre-dialysis care, less access to standardized training courses, or poor compliance contributed to the worse outcome observed in poorer patients. Regional SES-related information such as local hygiene status, availability of medical services and social support systems was not assessed in detail. Third, we should be aware of the possibility of ascertainment bias (4.1% of eligible patients were not included), vintage bias (different centers created their databases at different times), and residual confounding and recall bias because of the retrospective nature of this study. Furthermore, an observational study cannot demonstrate cause–effect relationships.
In conclusion, our findings strongly support the present health-care strategies implemented by the Chinese government to improve the medical coverage rate for ESRD patients. Our data also suggest that, under the present training program, the risk for peritonitis in less-educated patients is comparable with that in patients with higher diplomas. A series of strategies should be applied to improve the quality of treatment for poorer patients and less-educated patients in undeveloped region. Constructing an integrated care system for chronic kidney disease patients to prevent various complications and developing PD networks to standardize training programs may be potential approaches to improving the quality of therapy.
Acknowledgments
The authors express their appreciation to the patients, doctors, and nursing staff of the peritoneal dialysis center of Peking University First Hospital, Division of Nephrology of Peking University Third Hospital, Division of Nephrology of Huashan Hospital, Fudan University, Division of Nephrology of the second affiliated hospital of Harbin Medical University, Division of Nephrology of Peking University People’s Hospital, Division of Nephrology of the first affiliated hospital of Zhejiang University School of Medicine, Division of Nephrology of General Hospital of NingXia Medical University, for their participation in this study. The authors also thank ELIXIGEN (Shanghai) Corp. for native English speaking proofreading of the manuscript.
Author Contributions
Conceived and designed the experiments: HYW JD. Performed the experiments: RX QFH YPR TYZ JHC HPZ MHC YW CMH RZ XHZ MW NT. Analyzed the data: RX. Wrote the paper: RX JD.
References
- 1. Zhang L, Wang F, Wang L, Wang W, Liu B, et al. (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379: 815–822.
- 2. Zuo L, Wang M (2006) Current status of hemodialysis treatment in Beijing, China. Ethn Dis 16: S2–31–34.
- 3. Klarenbach S, Manns B (2009) Economic evaluation of dialysis therapies. Semin Nephrol 29: 524–532.
- 4. Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, et al. (2010) Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol 21: 499–506.
- 5.
ANZDATA website. The 30th Annual Report (2007). available: http://www.anzdata.org.au/anzdata/AnzdataReport/30thReport/Ch03Deaths.pdf.Accessed 2012 Oct 30.
- 6. Juergensen E, Wuerth D, Finkelstein SH, Juergensen PH, Bekui A, et al. (2006) Hemodialysis and peritoneal dialysis: patients' assessment of their satisfaction with therapy and the impact of the therapy on their lives. Clin J Am Soc Nephrol 1: 1191–1196.
- 7. Brown EA, Johansson L, Farrington K, Gallagher H, Sensky T, et al. (2010) Broadening Options for Long-term Dialysis in the Elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients. Nephrol Dial Transplant 25: 3755–3763.
- 8. Oliver MJ, Garg AX, Blake PG, Johnson JF, Verrelli M, et al. (2010) Impact of contraindications, barriers to self-care and support on incident peritoneal dialysis utilization. Nephrol Dial Transplant 25: 2737–2744.
- 9. Jager KJ, Korevaar JC, Dekker FW, Krediet RT, Boeschoten EW (2004) The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands. Am J Kidney Dis 43: 891–899.
- 10. Oliver MJ, Quinn RR, Richardson EP, Kiss AJ, Lamping DL, et al. (2007) Home care assistance and the utilization of peritoneal dialysis. Kidney Int 71: 673–678.
- 11. Adams AS, Mah C, Soumerai SB, Zhang F, Barton MB, et al. (2003) Barriers to self-monitoring of blood glucose among adults with diabetes in an HMO: a cross sectional study. BMC Health Serv Res 3: 6.
- 12. Goldman DP, Smith JP (2002) Can patient self-management help explain the SES health gradient? Proc Natl Acad Sci U S A 99: 10929–10934.
- 13. Kennedy BP, Kawachi I, Glass R, Prothrow-Stith D (1998) Income distribution, socioeconomic status, and self rated health in the United States: multilevel analysis. BMJ 317: 917–921.
- 14. Goldfarb-Rumyantzev AS, Rout P, Sandhu GS, Khattak M, Tang H, et al. (2010) Association between social adaptability index and survival of patients with chronic kidney disease. Nephrol Dial Transplant 25: 3672–3681.
- 15. Merkin SS, Roux AV, Coresh J, Fried LF, Jackson SA, et al. (2007) Individual and neighborhood socioeconomic status and progressive chronic kidney disease in an elderly population: The Cardiovascular Health Study. Soc Sci Med 65: 809–821.
- 16. Wee LE, Koh GC (2012) Individual and neighborhood social factors of hypertension management in a low-socioeconomic status population: a community-based case-control study in Singapore. Hypertens Res 35: 295–303.
- 17. Chichlowska KL, Rose KM, Diez-Roux AV, Golden SH, McNeill AM, et al. (2008) Individual and neighborhood socioeconomic status characteristics and prevalence of metabolic syndrome: the Atherosclerosis Risk in Communities (ARIC) Study. Psychosom Med 70: 986–992.
- 18. Volkova N, McClellan W, Klein M, Flanders D, Kleinbaum D, et al. (2008) Neighborhood poverty and racial differences in ESRD incidence. J Am Soc Nephrol 19: 356–364.
- 19.
Sanabria M, Munoz J, Trillos C, Hernandez G, Latorre C, et al.. (2008) Dialysis outcomes in Colombia (DOC) study: a comparison of patient survival on peritoneal dialysis vs hemodialysis in Colombia. Kidney Int Suppl: S165–172.
- 20. de Andrade Bastos K, Qureshi AR, Lopes AA, Fernandes N, Barbosa LM, et al. (2011) Family income and survival in Brazilian Peritoneal Dialysis Multicenter Study Patients (BRAZPD): time to revisit a myth? Clin J Am Soc Nephrol 6: 1676–1683.
- 21. Martin LC, Caramori JC, Fernandes N, Divino-Filho JC, Pecoits-Filho R, et al. (2011) Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis study (BRAZPD) patients. Clin J Am Soc Nephrol 6: 1944–1951.
- 22. Chidambaram M, Bargman JM, Quinn RR, Austin PC, Hux JE, et al. (2011) Patient and physician predictors of peritoneal dialysis technique failure: a population based, retrospective cohort study. Perit Dial Int 31: 565–573.
- 23. Farias MG, Soucie JM, McClellan W, Mitch WE (1994) Race and the risk of peritonitis: an analysis of factors associated with the initial episode. Kidney Int 46: 1392–1396.
- 24. Tonelli M, Hemmelgarn B, Culleton B, Klarenbach S, Gill JS, et al. (2007) Mortality of Canadians treated by peritoneal dialysis in remote locations. Kidney Int 72: 1023–1028.
- 25. Caskey FJ, Roderick P, Steenkamp R, Nitsch D, Thomas K, et al. (2006) Social deprivation and survival on renal replacement therapy in England and Wales. Kidney Int 70: 2134–2140.
- 26. Lim WH, Boudville N, McDonald SP, Gorham G, Johnson DW, et al. (2011) Remote indigenous peritoneal dialysis patients have higher risk of peritonitis, technique failure, all-cause and peritonitis-related mortality. Nephrol Dial Transplant 26: 3366–3372.
- 27.
Mehrotra R, Story K, Guest S, Fedunyszyn M (2011) Neighborhood Location, Rurality, Geography, and Outcomes of Peritoneal Dialysis Patients in the United States. Perit Dial Int.
- 28. Smith SC Jr, Jackson R, Pearson TA, Fuster V, Yusuf S, et al. (2004) Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Circulation 109: 3112–3121.
- 29. Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, et al. (2010) Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 30: 393–423.
- 30. Afolalu B, Troidle L, Osayimwen O, Bhargava J, Kitsen J, et al. (2009) Technique failure and center size in a large cohort of peritoneal dialysis patients in a defined geographic area. Perit Dial Int 29: 292–296.
- 31.
Mujais S, Story K (2006) Peritoneal dialysis in the US: evaluation of outcomes in contemporary cohorts. Kidney Int Suppl: S21–26.
- 32. Schaubel DE, Blake PG, Fenton SS (2001) Effect of renal center characteristics on mortality and technique failure on peritoneal dialysis. Kidney Int 60: 1517–1524.
- 33. Rubin J, Kirchner K, Ray R, Bower JD (1985) Demographic factors associated with dialysis technique failures among patients undergoing continuous ambulatory peritoneal dialysis. Arch Intern Med 145: 1041–1044.
- 34. Rubin J, Ray R, Barnes T, Teal N, Hellems E, et al. (1983) Peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 2: 602–609.
- 35. Raaijmakers R, Gajjar P, Schroder C, Nourse P (2010) Peritonitis in children on peritoneal dialysis in Cape Town, South Africa: epidemiology and risks. Pediatr Nephrol 25: 2149–2157.
- 36.
D Batlle PR, M J Soler (2006) Progress in retarding the progression of advanced chronic kidney disease: Grounds for optimism. Kidney International: S40–S44.
- 37. Pereira BJ (2000) Optimization of pre-ESRD care: the key to improved dialysis outcomes. Kidney Int 57: 351–365.
- 38. Carruthers DM, Whishaw JM, Thomas M, Thatcher G (1996) Planes, kangaroos, and the CAPD manual. Perit Dial Int 16 Suppl 1S452–454.
- 39. Carruthers D, Warr K (2004) Supporting peritoneal dialysis in remote Australia. Nephrology (Carlton) 9 Suppl 4S129–133.
- 40. Avram MM, Goldwasser P, Erroa M, Fein PA (1994) Predictors of survival in continuous ambulatory peritoneal dialysis patients: the importance of prealbumin and other nutritional and metabolic markers. Am J Kidney Dis 23: 91–98.
- 41. Blake PG, Flowerdew G, Blake RM, Oreopoulos DG (1993) Serum albumin in patients on continuous ambulatory peritoneal dialysis–predictors and correlations with outcomes. J Am Soc Nephrol 3: 1501–1507.
- 42. Leinig CE, Moraes T, Ribeiro S, Riella MC, Olandoski M, et al. (2011) Predictive value of malnutrition markers for mortality in peritoneal dialysis patients. J Ren Nutr 21: 176–183.
- 43. Xu R, Zhuo M, Yang Z, Dong J (2012) Experiences with assisted peritoneal dialysis in China. Perit Dial Int 32: 94–101.
- 44. Blake PG, Korbet SM, Blake R, Bargman JM, Burkart JM, et al. (2000) A multicenter study of noncompliance with continuous ambulatory peritoneal dialysis exchanges in US and Canadian patients. Am J Kidney Dis 35: 506–514.
- 45. Taira DA, Gelber RP, Davis J, Gronley K, Chung RS, et al. (2007) Antihypertensive adherence and drug class among Asian Pacific Americans. Ethn Health 12: 265–281.
- 46. Yang X, Mao HP, Guo QY, Yu XQ (2011) Successfully managing a rapidly growing peritoneal dialysis program in Southern China. Chin Med J (Engl) 124: 2696–2700.